Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 1,926,094 | 1,998,687 | 1,937,656 | 1,927,224 | 2,085,853 |
| Cost of Goods | 474,111 | 496,337 | 477,584 | 455,525 | 440,430 |
| Gross Profit | 1,451,983 | 1,502,350 | 1,460,072 | 1,471,699 | 1,645,423 |
| Operating Expenses | 550,125 | 673,306 | 481,583 | 479,597 | 484,712 |
| Operating Income | 901,969 | 829,381 | 979,073 | 992,627 | 1,161,141 |
| Interest Expense | 41,216 | 40,622 | 33,620 | 17,764 | 16,955 |
| Other Income | 13,832 | 10,764 | 15,593 | 18,285 | 15,645 |
| Pre-tax Income | 874,585 | 799,523 | 961,046 | 993,148 | 1,159,831 |
| Income Tax | 227,282 | 173,158 | 258,883 | 284,021 | 307,737 |
| Net Income Continuous | 647,303 | 626,365 | 702,163 | 709,127 | 852,094 |
| Minority Interests | -3,838 | -3,054 | -2,713 | -2,934 | -2,807 |
| Net Income | $651,141 | $629,419 | $704,876 | $712,061 | $854,901 |
| EPS Basic Total Ops | 0.41 | 0.39 | 0.43 | 0.41 | 0.48 |
| EPS Basic Continuous Ops | 0.41 | 0.39 | 0.42 | 0.40 | 0.47 |
| EPS Diluted Total Ops | 0.40 | 0.39 | 0.42 | 0.40 | 0.46 |
| EPS Diluted Continuous Ops | 0.40 | 0.39 | 0.41 | 0.39 | 0.46 |
| EBITDA(a) | $982,883 | $906,897 | $1,048,126 | $1,051,428 | $1,221,247 |